Bryniarski Krzysztof, Ptak Wlodzimierz, Martin Emilia, Nazimek Katarzyna, Szczepanik Marian, Sanak Marek, Askenase Philip W
Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America; Department of Immunology, Jagiellonian University Medical College, Krakow, Poland.
Department of Immunology, Jagiellonian University Medical College, Krakow, Poland.
PLoS One. 2015 Apr 29;10(4):e0122991. doi: 10.1371/journal.pone.0122991. eCollection 2015.
Lymph node and spleen cells of mice doubly immunized by epicutaneous and intravenous hapten application produce a suppressive component that inhibits the action of the effector T cells that mediate contact sensitivity reactions. We recently re-investigated this phenomenon in an immunological system. CD8+ T lymphocyte-derived exosomes transferred suppressive miR-150 to the effector T cells antigen-specifically due to exosome surface coat of antibody light chains made by B1a lymphocytes. Extracellular RNA (exRNA) is protected from plasma RNases by carriage in exosomes or by chaperones. Exosome transfer of functional RNA to target cells is well described, whereas the mechanism of transfer of exRNA free of exosomes remains unclear. In the current study we describe extracellular miR-150, extracted from exosomes, yet still able to mediate antigen-specific suppression. We have determined that this was due to miR-150 association with antibody-coated exosomes produced by B1a cell companions of the effector T cells, which resulted in antigen-specific suppression of their function. Thus functional cell targeting by free exRNA can proceed by transfecting companion cell exosomes that then transfer RNA cargo to the acceptor cells. This contrasts with the classical view on release of RNA-containing exosomes from the multivesicular bodies for subsequent intercellular targeting. This new alternate pathway for transfer of exRNA between cells has distinct biological and immunological significance, and since most human blood exRNA is not in exosomes may be relevant to evaluation and treatment of diseases.
通过表皮和静脉内应用半抗原双重免疫的小鼠的淋巴结和脾细胞产生一种抑制成分,该成分可抑制介导接触敏感性反应的效应T细胞的作用。我们最近在一个免疫系统中重新研究了这一现象。由于B1a淋巴细胞产生的抗体轻链构成的外泌体表面涂层,CD8 + T淋巴细胞衍生的外泌体将抑制性miR-150特异性地转移至效应T细胞。细胞外RNA(exRNA)通过外泌体携带或分子伴侣保护而免受血浆核糖核酸酶的影响。外泌体将功能性RNA转移至靶细胞的过程已有详细描述,而游离于外泌体的exRNA的转移机制仍不清楚。在本研究中,我们描述了从外泌体中提取的细胞外miR-150,其仍能够介导抗原特异性抑制作用。我们确定这是由于miR-150与效应T细胞的B1a细胞伴侣产生的抗体包被的外泌体结合,从而导致其功能的抗原特异性抑制。因此,游离exRNA的功能性细胞靶向可通过转染伴侣细胞外泌体来实现,然后这些外泌体将RNA货物转移至受体细胞。这与关于从多囊泡体释放含RNA外泌体以进行后续细胞间靶向的经典观点形成对比。这种细胞间exRNA转移的新替代途径具有独特的生物学和免疫学意义,并且由于大多数人血液中的exRNA不在外泌体中,可能与疾病的评估和治疗相关。